PER 1.23% 8.0¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-29

  1. 268 Posts.
    lightbulb Created with Sketch. 28
    JG does a great interview carry's himself very well, every aspect of his interview was very positive, I will be in for more that's for sure, partner could come out of the blue at any time, exciting times
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.